Macro Biologics
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$18.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Macro Biologics is a biotechnology company that develops synthetic biological polymers for breakthrough therapeutics, next-generation medical devices, and advanced biomaterials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Macro Biologics Comparables
Compare Macro Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prevent-Plus, LLC | 77% | |
| Imbed Biosciences | 76% | |
| Amferia | 74% |
Macro Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Series A | Sep 4, 2024 | ||||
| Early Funding | Aug 14, 2023 | ||||
| Grant | Jun 6, 2023 | ||||
| Grant | Jun 22, 2020 | ||||
Convertible Debt | Feb 12, 2020 |
Key People
Founding team and executive leadership
Macro Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| CARB-X | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| U.S. Department of War | Grant |
| Oscar & Paul Beiersdorf Venture Capital | Series A |
| Impact Foundation | Early Funding, Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 36% MoM.
- May 16, 2026
Monthly visitors grew 117% MoM.
Macro Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Macro Biologics's valuation, stock price, and market status.
Is Macro Biologics a public or private company?
Macro Biologics is a private company.
What is the current stock price of Macro Biologics?
Macro Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Macro Biologics worth (valuation)?
Valuation information for Macro Biologics is not publicly available.
Can I buy Macro Biologics stock?
Macro Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Macro Biologics's last funding round?
Funding round information for Macro Biologics is not publicly available.
Who are the main investors in Macro Biologics?
Investor information for Macro Biologics is not publicly disclosed.
Will Macro Biologics IPO soon?
No public IPO plans have been announced for Macro Biologics.
How can I track Macro Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Macro Biologics's secondary market activity and sign up for updates.